Efficacious diagnosis of primary and metastatic human carcinomas with a combination of p53 mutation analysis and clonality analysis of androgen receptor gene

被引:0
|
作者
Aotake, T
Muraoka, R
Matsukawa, S
Tanigawa, N
机构
[1] Fukui Med Univ, Dept Surg 2, Matsuoka, Fukui 91011, Japan
[2] Fukui Med Univ, Cent Res Labs, Matsuoka, Fukui 91011, Japan
[3] Osaka Med Coll, Dept Gen & Gastroenterol Surg, Takatsuki, Osaka 569, Japan
关键词
p53; gene; PCR-SSCP; human androgen receptor gene; clonality analysis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is occasionally difficult to differentiate between multiple primary and metastatic tumors in case of multiple carcinomas, p53 gene mutation pattern by PCR-SSCP and a clonality analysis on the human androgen receptor gene (HUMARA) in multiple tumors were used to distinguish whether carcinomas were multiple primary tumors or a metastasis. Three female patients with multiple carcinomas, who had undergone surgical resection, were selected for these analyses as typical candidates from ii cases tested. In the first case with bilateral breast cancer the combined analyses were performed on DNA extracted from tumor portions in paraffin sections of each tumor sample and the results indicated that the carcinomas consisted of a primary carcinoma and metastatic tumors. The carcinomas in the second patient consisted of multiple primary carcinomas and the tumors in the third patient consisted of two independent primary carcinomas with different clonal origins. Thus a combination of p53 gene mutation analysis and clonality analysis on HUMARA provided useful. reliable evidence which can help in discriminating multiple primary tumors from metastatic tumors.
引用
收藏
页码:773 / 779
页数:7
相关论文
共 50 条
  • [11] p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma
    van Rens, MTM
    Eijken, EJE
    Elbers, JRJ
    Lammers, JWJ
    Tilanus, MGJ
    Slootweg, PJ
    CANCER, 2002, 94 (01) : 188 - 196
  • [12] Clonality and stability of the p53 gene in human astrocytic tumor cells: Quantitative analysis of p53 gene mutations by yeast functional assay
    Tada, M
    Iggo, RD
    Ishii, N
    Shinohe, Y
    Sakuma, S
    Estreicher, A
    Sawamura, Y
    Abe, H
    INTERNATIONAL JOURNAL OF CANCER, 1996, 67 (03) : 447 - 450
  • [13] Determination of primary foci of metastatic tumors by p53 mutational analysis in intraesophageal multiple carcinomas
    Kuwabara, S
    Nishimaki, T
    Ajioka, Y
    Komukai, S
    Suzuki, T
    Watanabe, H
    Hatakeyama, K
    DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (08) : 1675 - 1677
  • [14] Immunohistochemical analysis of p53 expression in primary breast carcinomas
    Naidu, R
    Yadav, M
    Nair, S
    Kutty, KK
    ANTICANCER RESEARCH, 1998, 18 (1A) : 65 - 70
  • [15] Expression and mutation analysis of the p53 gene in astrocytoma
    Hwang, SL
    Hong, YR
    Sy, WD
    Chai, CY
    Lin, HJ
    Howng, SL
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1999, 98 (01) : 31 - 38
  • [16] THE P53 GENE IN HUMAN HEPATOCELLULAR CARCINOMAS
    TERRIS, B
    MARCIO, A
    TIOLLAIS, P
    DEJEAN, A
    JOURNAL OF HEPATOLOGY, 1993, 17 (03) : 422 - 422
  • [17] IMMUNOCHEMICAL ANALYSIS OF THE P53 ONCOPROTEIN IN MATCHED PRIMARY AND METASTATIC HUMAN TUMORS
    BARTKOVA, J
    BARTEK, J
    VOJTESEK, B
    LUKAS, J
    REJTHAR, A
    KOVARIK, J
    MILLIS, RR
    LANE, DP
    BARNES, DM
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (06) : 881 - 886
  • [18] ANALYSIS OF THE P53 GENE IN EUROPEAN HEPATOCELLULAR CARCINOMAS AND HEPATOBLASTOMAS
    DEBUIRE, B
    PATERLINI, P
    PONTISSO, P
    BASSO, G
    MAY, E
    ONCOGENE, 1993, 8 (08) : 2303 - 2306
  • [19] P53 GENE MUTATION SPECTRUM IN HUMAN UNKNOWN PRIMARY TUMORS
    BARELI, M
    ABBRUZZESE, JL
    LEEJACKSON, D
    FROST, P
    ANTICANCER RESEARCH, 1993, 13 (5A) : 1619 - 1623
  • [20] IMMUNOHISTOCHEMICAL ANALYSIS OF P53 EXPRESSION IN HUMAN PANCREATIC CARCINOMAS
    ZHANG, SY
    RUGGERI, B
    AGARWAL, P
    SORLING, AF
    OBARA, T
    URA, H
    NAMIKI, M
    KLEINSZANTO, AJP
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1994, 118 (02) : 150 - 154